Announcement on the resolution of the third meeting of the sixth board of supervisors
Securities code: Guangdong Jiaying Pharmaceutical Co.Ltd(002198) securities abbreviation: Guangdong Jiaying Pharmaceutical Co.Ltd(002198) Announcement No.: 2022010 Guangdong Jiaying Pharmaceutical Co.Ltd(002198)
Announcement of the third meeting of the board of supervisors
The company and all members of the board of supervisors guarantee that the contents of this announcement are true, accurate and complete, and there are no false records, misleading statements or major omissions.
1、 Meetings of the board of supervisors
1. Guangdong Jiaying Pharmaceutical Co.Ltd(002198) (hereinafter referred to as “the company”) the notice of the third meeting of the sixth board of supervisors has been delivered to all supervisors of the company by hand, e-mail or fax on February 28, 2022. On March 10, 2022, the meeting was held on site in Meizhou, Guangdong as scheduled.
2. Two supervisors should be present at the meeting, and two actually present.
3. With the consent of all participants, the meeting was presided over by Mr. Lai yichai, the supervisor.
4. The convening and convening of the meeting shall comply with the provisions of laws, regulations and the articles of association, and the resolutions formed by voting shall be legal and effective.
2、 Deliberation at the meeting of the board of supervisors
The meeting adopted the following proposals by voting:
1. The meeting deliberated and adopted the proposal on the company’s work report of the board of supervisors in 2021 with 2 affirmative votes, 0 negative votes and 0 abstention.
For details, please refer to the company’s website on March 12, 2022 (www.cn. Info. Com. CN.) Work report of the board of supervisors in 2021 disclosed on the.
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
2. The meeting deliberated and adopted the proposal on the company’s annual financial final report in 2021 with 2 affirmative votes, 0 negative votes and 0 abstention.
For details, please refer to the company’s website on March 12, 2022 (www.cn. Info. Com. CN.) 2021 annual financial statement disclosed on the.
Announcement on the resolution of the third meeting of the sixth board of supervisors
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
3. The meeting deliberated and adopted the proposal on the company’s profit distribution plan for 2021 by 2 votes in favor, 0 against and 0 abstention.
Audited by zhongxinghua certified public accountants, the total comprehensive income of the company’s consolidated income statement in 2021 was 147726972 yuan. With the audited undistributed profit of 2486665588 yuan at the end of 2020, the undistributed profit of the company’s consolidated balance sheet at the end of 2021 was 2634392560 yuan. The total comprehensive income of the company (parent company) in 2021 is -2406920401 yuan. According to the articles of association, plus the audited undistributed profit of -23286095016 yuan at the end of 2020, the undistributed profit of the parent company at the end of 2021 is -25693015417 yuan.
The company plans not to distribute profits or convert capital reserve into share capital this year.
The board of supervisors believes that the profit distribution plan is in line with the actual situation and long-term development strategy of the company, does not harm the interests of shareholders, and complies with relevant laws, regulations, normative documents and other relevant provisions, and agrees with the company’s profit distribution plan for 2021.
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
4. The meeting deliberated and adopted the proposal on the company’s annual report in 2021 and the summary of the annual report in 2021 with 2 affirmative votes, 0 negative votes and 0 abstention.
For details, please refer to the company’s website (www.cn. Info. Com. CN.) The annual report of 2021 (Announcement No.: 2022007) disclosed on, and on the securities times, China Securities News, securities daily and cninfo (www.cn. Info. Com. CN.) Abstract of annual report for 2021 (Announcement No.: 2022008) disclosed on.
The board of supervisors believes that the procedures for the board of directors to prepare and review the company’s annual report 2021 and the summary of the annual report 2021 comply with laws, administrative regulations and the provisions of the CSRC. The contents of the report truly, accurately and completely reflect the actual situation of the company in 2021, and there are no false records, misleading statements or major omissions.
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
5. The meeting deliberated and adopted the proposal on the company’s self-evaluation report on internal control in 2021 with 2 affirmative votes, 0 negative votes and 0 abstention.
Announcement on the resolution of the third meeting of the sixth board of supervisors
For details, please refer to the company’s website (www.cn. Info. Com. CN.) Self evaluation report on internal control in 2021 disclosed on.
The board of supervisors believes that the company has established an internal control system related to financial reporting and information disclosure in accordance with the provisions of the basic norms of enterprise internal control and its supporting guidelines and other internal control regulatory requirements, and the implementation of relevant internal control in 2021 is effective. The company’s self-evaluation report on internal control in 2021 comprehensively, truly and objectively reflects the construction and operation of the company’s internal control system.
3、 Documents for future reference
1. Resolution of the third meeting of the sixth board of supervisors.
It is hereby announced.
Guangdong Jiaying Pharmaceutical Co.Ltd(002198) board of supervisors
March 10, 2022
